The SciTech e-Merging News is published quarterly as a Section member benefit. Click here to join the Section. The material published reflects the views of the authors and has not been approved by the Section of Science & Technology Law, the House of Delegates or the Board of Governors of the ABA. © 2009 American Bar Association. All rights reserved.
Faithful BioBlurb readers, thanks for waiting patiently during the changing of the guard (of our editors, that is).
We've said good-bye, sadly, to our editor extraordinaire of the past two years, Lisa von Biela. (Lisa is studying for the bar examination and preparing for the full-time practice of law.) While we wait for our official 2009-10 Blurb leadership to take over, an interim editorial team from the Committee on Biotechnology will keep the BioBlurb coming your way.
Please do keep sending your contributions to the Blurb to email@example.com. Thanks to Hugh Wellons for providing a lot of this week's material!
Research Breakthroughs :
"Novartis, Fate Race to Develop Stem Cell Drug for Transplants." For thousands of blood cancer victims who need a bone marrow transplant or umbilical cord blood but can't find a match, the competition between Fate Therapeutics and Novartis to develop a stem cell therapy is good news regardless who gets there first, reports Bloomberg.com (July 9, 2009).
"Easter Island Wonder Drug 'Adds Decade to Life.'" Researchers at the Jackson Laboratory believe that rapamycin, a bacterial product found in soil samples in the South Pacific, could extend the human lifespan, by inhibiting a protein that plays a key role in cell growth, reports The Sun (July 9, 2009).
"Australian Scientists Kill Cancer Cells with 'Trojan Horse.'" The therapy uses a bacterially-derived nano cell as a "Trojan horse" to penetrate and disarm a cancer cell before a second nano cell kills it with chemotherapy drugs, according to Yahoo! News (June 28, 2009).
"Hundreds of Genes May Be Linked to ADHD." Findings published in Molecular Psychiatry may offer a partial explanation of why there are so many variations in how ADHD patients present clinically, according to Yahoo! News (June 25, 2009).
"Study Endorses Longer Market Exclusivity for Drugmakers." The National Venture Capital Association released study results supporting a longer period of market exclusivity for biologic drugmakers before follow-ons are allowed on the market, according to a Wall Street Journal blog (July 13, 2009).
Intellectual Property Issues:
SBIR Grants for Biotech Startups:
Health Care Reform:
"Health Care Deadline Unlikely to Be Met ." President Obama's August deadline for health care reforms seems unlikely to be met, according to Politico (July 9, 2009).
Key Political Appointments:
"Alabama Physician Chosen as Surgeon General." President Obama has chosen Dr. Regina Benjamin, a family physician whose clinic served Hurricane Katrina victims and who received a MacArthur Foundation "genius" grant last year, as the next U.S. Surgeon General, says The New York Times (July 13, 2009).
And, As Always, Weird News:
"Study: Ugly Men More Fertile, Produce More Sperm During Sex." A study suggests that women seeking to get pregnant have a better chance with an ugly partner, reports Fox News (July 10, 2009).
Eileen Smith Ewing
Bio Blurb is a member benefit of the Biotechnology Law Committee. Join the Committee for free to receive your regular issue.